CARLSBAD, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced the execution of an amended credit facility with Wells Fargo Bank, NA (“Wells Fargo”). This amendment modifies the current facility extending the term of the agreement to December 31, 2026 and modifies the borrowing capacity to $10 million. Mark A. Le Doux, Chairman and Chief Executive Offic ...

GALWAY, Ireland, June 23, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its Board of Directors appointed Dr. Joon Lee, CEO at Emory Healthcare, Inc., to the Board as an independent director, effective June 18, 2025. Dr. Lee will serve on the Science and Technology Committee and Compensation and Talent Committee of the Board."We are thrilled to welcome Dr. Lee, a highly respected interventional cardiologist and healthcare executive, to Medtroni ...

BETHESDA, MD, June 23, 2025 (GLOBE NEWSWIRE) -- Alset Inc. (NASDAQ:AEI) ("AEI" or the "Company"), a diversified holding company principally engaged through its subsidiaries in the development of smart and sustainable home communities and other property development, financial services, digital transformation technologies, biohealth activities and consumer products, is pleased to announce that its Board of Directors has authorized a new stock repurchase program of up to $1,000,000 of the Company’s outstanding ...

ELKHART, Ind., June 23, 2025 (GLOBE NEWSWIRE) -- THOR Industries, Inc. (NYSE: THO) today announced that its Board of Directors has retired the Company’s existing share repurchase authorization which was set to expire on July 31, 2025 and re-authorized the Company to repurchase up to $400 million of its Common Stock. The Company may purchase shares on a discretionary basis from time to time through open market purchases, privately negotiated transactions or other means. The timing and amount of any transacti ...

Apple is reportedly in eleventh-hour negotiations with European regulators about changes to its App Store.By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions .Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.As the Financial Times (FT) reported Monday (June 23), the t ...

Financial Performance - The company incurred net losses of approximately $288.7 million, $279.7 million, and $268.8 million for the fiscal years ended April 30, 2025, 2024, and 2023 respectively, resulting in an accumulated deficit of $1.4 billion as of April 30, 2025[174]. - The company expects to continue incurring net losses for the foreseeable future due to substantial investments in customer acquisition and software development[174]. - Increased compliance costs and operational expenses may negatively affect future results if revenue does not increase sufficiently[175]. - Revenue metrics such as net dollar-based retention rate may not accurately indicate future financial results due to dependence on a small number of high-value customer contracts[196]. - A decline in new or renewed subscriptions may have a small immediate impact but will negatively affect future revenue[229]. - The company may require additional financing in the future, which could lead to substantial dilution for existing stockholders if equity is sold[266]. - The company has limited experience in acquisitions and may face challenges in finding suitable candidates or integrating acquired businesses effectively[267]. Revenue and Customer Dynamics - Revenue growth may be adversely impacted by factors such as reduced demand for C3 AI Software, increased competition, and the inability to accurately forecast demand[176]. - A limited number of customers have historically accounted for a substantial portion of revenue, and if these customers do not renew contracts, revenue could decline[177]. - The average total subscription contract value is decreasing as the company expands its customer base beyond a small number of large customers[177]. - Future success depends on the ability to sell additional subscriptions to existing customers and ensure their renewal upon contract expiration[181]. - The company intends to grow its customer base by introducing product offerings with a lower entry price point, but faces risks associated with supporting smaller customers[182]. - The company derives substantially all of its revenue from subscriptions to C3 AI Software and Center of Excellence support services, making market acceptance critical for continued success[184]. - Future revenue growth depends on the ability to establish and maintain successful strategic partner relationships, which requires significant time and resources[202]. Competition and Market Risks - The company faces intense competition from various sources, including larger competitors with broader offerings and innovative startups[187]. - Changes in subscription or pricing models may adversely affect operating results, especially as new competitors enter the market[197]. - The introduction of new AI platforms by competitors could render C3 AI Software obsolete, adversely affecting business and financial condition[210]. - The market for C3 AI Software may not grow as expected, impacting business and financial condition if businesses fail to adopt the software[205]. Operational Challenges - The sales cycles for C3 AI Software can be long and unpredictable, particularly for large subscriptions, which may extend over several years[194]. - Individual large sales can represent a significant portion of overall sales, impacting cash flow and margins, making it difficult to project revenue accurately[195]. - Rapid growth since 2009 has placed significant strain on management and operational resources, which may affect future growth planning[217]. - Recruiting and training qualified sales representatives is resource-intensive, and delays in this process could hinder sales operations[213]. - Marketing and sales efforts must generate significant revenue increases; otherwise, sales growth may be slower than anticipated[214]. Compliance and Regulatory Risks - Compliance with evolving data privacy laws, such as GDPR and CCPA, imposes significant obligations and potential fines for noncompliance[236][240]. - The inability to lawfully transfer personal data across borders may lead to operational disruptions and increased regulatory scrutiny[238]. - The company faces increased compliance costs and potential liabilities due to stringent data protection laws in various jurisdictions[239]. - Future changes in data privacy regulations may require significant adaptations in business practices and contractual arrangements[239]. - The EU AI Act, effective from August 1, 2024, could impose fines of up to €35 million or 7% of the company's total worldwide annual turnover for non-compliance[241]. Cybersecurity and Data Protection - Cybersecurity threats, including ransomware and denial-of-service attacks, are increasing and could disrupt business operations and lead to reputational harm[245]. - The costs associated with responding to a security breach could be significant, potentially leading to unexpected interruptions and negative publicity[248]. - The company may face increased compliance burdens and costs due to rapidly evolving laws and regulations regarding data privacy and security[248]. - The company’s C3 AI Software processes sensitive data, and any security incidents could result in significant legal and financial consequences[244]. Intellectual Property and Legal Risks - The company holds a patent portfolio with 35 issued patents in the U.S. and over 60 pending applications, indicating a strong focus on intellectual property protection[297]. - The company may incur substantial indemnity payments due to intellectual property infringement claims, which could harm its financial results[296]. - The company faces potential legal risks related to the use of third-party open source software, which could lead to significant legal expenses and damages[298]. - The enforceability of the Apache License, Version 2.0, under which components of the C3 AI Software are provided, could negatively impact the company's software development and licensing model[302]. Market and Stock Performance - The trading price of the company's Class A common stock has been volatile, influenced by various factors including market fluctuations and sales by stockholders[304]. - The dual class structure of the company's common stock concentrates voting control with Class B stockholders, limiting the influence of Class A stockholders on corporate matters[309]. - Substantial future sales of Class A and Class B common stock could depress the market price of Class A common stock[312]. - The company may not be included in certain stock indices due to its dual class capital structure, potentially affecting its attractiveness to investors[311]. Foreign Operations and Currency Risks - The company is exposed to risks associated with fluctuations in foreign currency exchange rates as it expands international operations[258]. - 6% of revenue for the fiscal years ended April 30, 2025 and 2024 were denominated in currencies other than U.S. dollars[258]. - 7% of expenses for the fiscal years ended April 30, 2025 and 2024 were denominated in currencies other than U.S. dollars[258]. - A hypothetical 10% change in foreign currency exchange rates may result in a material impact on consolidated financial statements[465]. Miscellaneous Risks - Legal proceedings may arise that could negatively impact the company's business and financial condition[328]. - Catastrophic events could disrupt the company's operations, particularly given its location in a seismically active region[329]. - The company is subject to significant legal, accounting, and compliance costs as a public company, which may impact its financial condition[321].

Phase 1 clinical study of TERN-601 demonstrated differentiated profile in 28-day study; topline data were presented in September 2024 Phase 2 FALCON clinical trial of TERN-601 completed enrollment; 12-week data expected in 4Q 2025 FOSTER CITY, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and ...

Table of Contents | UNITED STATES | | | --- | --- | | SECURITIES AND EXCHANGE COMMISSION | | | Washington, D.C. 20549 | | | FORM 10-Q | | | (MARK ONE) | | | ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF | | | 1934 | | | For the quarterly period ended March 31, 2025 | | | ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF | | | 1934 | | | For the transition period from | to | | Commission File Number: 001-42636 | | | EGH ACQUISITION CO ...

NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Digimarc Corporation (NASDAQ: DMRC) between May 3, 2024 and February 26, 2025, both dates inclusive (the “Class Period”), of the important July 8, 2025 lead plaintiff deadline. SO WHAT: If you purchased Digimarc securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WH ...

STAMFORD, Conn., June 23, 2025 (GLOBE NEWSWIRE) -- With summer travel season in full swing, KAYAK has released new insights to help travelers avoid one of the most frustrating parts of flying: delays. Drawing from summer flight data last year, KAYAK's latest analysis pinpoints the most delay-prone times during the day, worst days and busiest airports – plus expert tips on how to fly smarter right now. Key Findings: JFK (New York), CLT (Charlotte), and MIA (Miami) reported the highest percentage of delays am ...